{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:15:42Z","timestamp":1790223342911,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ebiom.2020.103052","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T21:39:24Z","timestamp":1602193164000},"page":"103052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4268-2391","authenticated-orcid":false,"given":"Pasqualina","family":"Colella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Sellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel J.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Biferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Tanniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Guerchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Cohen-Tannoudji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"Moya-Nilges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"van Wittenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Daniele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Gjata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacomina","family":"Krijnse-Locker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Collaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Simon-Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut","family":"Cagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Mingozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ebiom.2020.103052_bib0001","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet Med"},{"issue":"9646","key":"10.1016\/j.ebiom.2020.103052_bib0002","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2020.103052_bib0003","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13023-016-0442-y","article-title":"Childhood Pompe disease: clinical spectrum and genotype in 31 patients","volume":"11","author":". van Capelle","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2020.103052_bib0004","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2016.12.004","article-title":"The emerging phenotype of late-onset Pompe disease: a systematic literature review","volume":"120","author":"Chan","year":"2017","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1016\/j.ebiom.2020.103052_bib0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.ebiom.2020.103052_bib0006","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000252798.25690.76","article-title":"Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype","volume":"68","author":"Kroos","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ebiom.2020.103052_bib0007","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajmg.c.31318","article-title":"The genotype-phenotype correlation in Pompe disease","volume":"160C","author":"Kroos","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.ebiom.2020.103052_bib0008","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ebiom.2019.03.048","article-title":"A genetic modifier of symptom onset in Pompe disease","volume":"43","author":". Bergsma","year":"2019","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.ebiom.2020.103052_bib0009","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/GIM.0b013e3181d2900e","article-title":"The angiotensin-converting enzyme insertion\/deletion polymorphism modifies the clinical outcome in patients with Pompe disease","volume":"12","author":". de Filippi","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.ebiom.2020.103052_bib0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13023-014-0102-z","article-title":"Genotype-phenotype correlation in Pompe disease, a step forward","volume":"9","author":"De Filippi","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ebiom.2020.103052_bib0011","first-page":"48","article-title":"The influence of a polymorphism in the gene encoding angiotensin converting enzyme (ACE) on treatment outcomes in late-onset Pompe patients receiving alglucosidase alfa","volume":"8","author":"Baek","year":"2016","journal-title":"Mol Genet Metab Rep"},{"issue":"12","key":"10.1016\/j.ebiom.2020.103052_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208854","article-title":"The ACE I\/D polymorphism does not explain heterogeneity of natural course and response to enzyme replacement therapy in Pompe disease","volume":"13","author":"Kuperus","year":"2018","journal-title":"PLoS One"},{"issue":"30","key":"10.1016\/j.ebiom.2020.103052_bib0013","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.ebiom.2020.103052_bib0014","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s13311-018-0655-y","article-title":"Pompe disease: from basic science to therapy","volume":"15","author":"Kohler","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.ebiom.2020.103052_bib0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/1566523215666150630132253","article-title":"Preclinical development of new therapy for glycogen storage diseases","volume":"15","author":"Sun","year":"2015","journal-title":"Curr Gene Ther"},{"issue":"8","key":"10.1016\/j.ebiom.2020.103052_bib0016","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/NEN.0b013e3181815994","article-title":"Temporal neuropathologic and behavioral phenotype of 6neo\/6neo Pompe disease mice","volume":"67","author":"Sidman","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"10.1016\/j.ebiom.2020.103052_bib0017","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ymthe.2006.08.009","article-title":"Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease","volume":"14","author":"Fukuda","year":"2006","journal-title":"Mol Ther"},{"issue":"24","key":"10.1016\/j.ebiom.2020.103052_bib0018","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1093\/hmg\/ddn292","article-title":"Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease","volume":"17","author":"Raben","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ebiom.2020.103052_bib0019","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.resp.2016.02.007","article-title":"Neuropathology in respiratory-related motoneurons in young Pompe (Gaa(-\/-)) mice","volume":"227","author":"Turner","year":"2016","journal-title":"Respir Physiol Neurobiol"},{"issue":"3","key":"10.1016\/j.ebiom.2020.103052_bib0020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/hmg\/ddu476","article-title":"Peripheral nerve and neuromuscular junction pathology in Pompe disease","volume":"24","author":"Falk","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"418","key":"10.1016\/j.ebiom.2020.103052_bib0021","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam6375","article-title":"Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid alpha-glucosidase","volume":"9","author":"Puzzo","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2020.103052_bib0022","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1038\/mtm.2015.7","article-title":"Comparative impact of AAV and enzyme replacement therapy on respiratory and cardiac function in adult Pompe mice","volume":"2","author":"Falk","year":"2015","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"9","key":"10.1016\/j.ebiom.2020.103052_bib0023","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/mt.2013.96","article-title":"Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease","volume":"21","author":"Falk","year":"2013","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.ebiom.2020.103052_bib0024","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.mt.6300100","article-title":"Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectors","volume":"15","author":"Mah","year":"2007","journal-title":"Mol Ther"},{"issue":"23","key":"10.1016\/j.ebiom.2020.103052_bib0025","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","article-title":"Neural deficits contribute to respiratory insufficiency in Pompe disease","volume":"106","author":"DeRuisseau","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.ebiom.2020.103052_bib0026","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/mt.2009.305","article-title":"Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease","volume":"18","author":"Mah","year":"2010","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2020.103052_bib0027","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/hum.2018.016","article-title":"Systemic delivery of AAVB1-GAA clears glycogen and prolongs survival in a mouse model of Pompe disease","volume":"30","author":"Keeler","year":"2019","journal-title":"Hum Gene Ther"},{"issue":"1-2","key":"10.1016\/j.ebiom.2020.103052_bib0028","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ymgme.2011.06.012","article-title":"Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease","volume":"104","author":"van der Beek","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ebiom.2020.103052_bib0029","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-6-34","article-title":"Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy","volume":"6","author":". Gungor","year":"2011","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2020.103052_bib0030","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","article-title":"Disease severity in children and adults with Pompe disease related to age and disease duration","volume":"64","author":"Hagemans","year":"2005","journal-title":"Neurology"},{"issue":"8-9","key":"10.1016\/j.ebiom.2020.103052_bib0031","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neurol.2013.07.002","article-title":"et al. The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe disease","volume":"169","author":"Laforet","year":"2013","journal-title":"Rev Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2020.103052_bib0032","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.resp.2013.06.007","article-title":"The respiratory neuromuscular system in Pompe disease","volume":"189","author":"Fuller","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"issue":"3","key":"10.1016\/j.ebiom.2020.103052_bib0033","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1203\/PDR.0b013e3181b24e94","article-title":"Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease","volume":"66","author":"Kishnani","year":"2009","journal-title":"Pediatr Res"},{"issue":"15","key":"10.1016\/j.ebiom.2020.103052_bib0034","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ebiom.2020.103052_bib0035","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10545-014-9728-1","article-title":"Effectiveness of enzyme replacement therapy in adults with late-onset Pompe disease: results from the NCS-LSD cohort study","volume":"37","author":"Anderson","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2020.103052_bib0036","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00415-016-8219-8","article-title":"Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis","volume":"264","author":"Schoser","year":"2017","journal-title":"J Neurol"},{"issue":"1-2","key":"10.1016\/j.ebiom.2020.103052_bib0037","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ymgme.2017.06.007","article-title":"Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme(R)) in 12 patients with advanced late-onset Pompe disease","volume":"122","author":"Papadopoulos","year":"2017","journal-title":"Mol Genet Metab"},{"issue":"9","key":"10.1016\/j.ebiom.2020.103052_bib0038","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/gim.2012.44","article-title":"The emerging phenotype of long-term survivors with infantile Pompe disease","volume":"14","author":"Prater","year":"2012","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.ebiom.2020.103052_bib0039","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/dmcn.13740","article-title":"Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain","volume":"60","author":"Ebbink","year":"2018","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"10.1016\/j.ebiom.2020.103052_bib0040","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/mt.2014.138","article-title":"A chaperone enhances blood alpha-glucosidase activity in Pompe disease patients treated with enzyme replacement therapy","volume":"22","author":"Parenti","year":"2014","journal-title":"Mol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.ebiom.2020.103052_bib0041","first-page":"114","article-title":"New therapeutic approaches for Pompe disease: enzyme replacement therapy and beyond","volume":"12","author":"Kishnani","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"issue":"12","key":"10.1016\/j.ebiom.2020.103052_bib0042","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1172\/JCI39845","article-title":"Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice","volume":"119","author":"Heydemann","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2020.103052_bib0043","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/131436","article-title":"Biochemical and functional comparisons of mdx and Sgcg(-\/-) muscular dystrophy mouse models","volume":"2015","author":"Roberts","year":"2015","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/j.ebiom.2020.103052_bib0044","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.23819","article-title":"LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy","volume":"73","author":"Flanigan","year":"2013","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.ebiom.2020.103052_bib0045","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp-2014-308409","article-title":"Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants","volume":"86","author":"van den Bergen","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.ebiom.2020.103052_bib0046","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ana.25283","article-title":"Long-range genomic regulators of THBS1 and LTBP4 modify disease severity in duchenne muscular dystrophy","volume":"84","author":"Weiss","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2020.103052_bib0047","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.omtm.2018.11.002","article-title":"AAV gene transfer with tandem promoter design prevents anti-transgene immunity and provides persistent efficacy in neonate Pompe mice","volume":"12","author":"Colella","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.ebiom.2020.103052_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2020.05.025","article-title":"Rescue of advanced Pompe disease in mice with hepatic expression of secretable acid alpha-glucosidase","author":"Cagin","year":"2020","journal-title":"Mol Ther"},{"issue":"16","key":"10.1016\/j.ebiom.2020.103052_bib0049","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1073\/pnas.96.16.8861","article-title":"Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase","volume":"96","author":"Amalfitano","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.ebiom.2020.103052_bib0050","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/emmm.201202176","article-title":"Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease","volume":"5","author":"Spampanato","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ebiom.2020.103052_bib0051","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/1471-2164-13-460","article-title":"CTen: a web-based platform for identifying enriched cell types from heterogeneous microarray data","volume":"13","author":"Shoemaker","year":"2012","journal-title":"BMC Genom"},{"issue":"6","key":"10.1016\/j.ebiom.2020.103052_bib0052","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/156652310793797685","article-title":"purification and characterization of adeno-associated vectors","volume":"10","author":"Ayuso","year":"2010","journal-title":"Curr Gene Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2020.103052_bib0053","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/exnr.1999.7082","article-title":"Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination","volume":"158","author":"McGavern","year":"1999","journal-title":"Exp Neurol"},{"issue":"10","key":"10.1016\/j.ebiom.2020.103052_bib0054","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/cdd.2012.52","article-title":"The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII)","volume":"19","author":"Nascimbeni","year":"2012","journal-title":"Cell Death Differ"},{"issue":"1","key":"10.1016\/j.ebiom.2020.103052_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Klionsky","year":"2016","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.ebiom.2020.103052_bib0056","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125358","article-title":"Improved efficacy of a next-generation ERT in murine Pompe disease","volume":"4","author":"Xu","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.ebiom.2020.103052_bib0057","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ajmg.c.31317","article-title":"Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten","volume":"160C","author":"Raben","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"2","key":"10.1016\/j.ebiom.2020.103052_bib0058","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/15548627.2015.1009779","article-title":"Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease","volume":"11","author":"Lim","year":"2015","journal-title":"Autophagy"},{"issue":"13","key":"10.1016\/j.ebiom.2020.103052_bib0059","doi-asserted-by":"crossref","first-page":"289","DOI":"10.21037\/atm.2019.04.49","article-title":"An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond","volume":"7","author":"Korlimarla","year":"2019","journal-title":"Ann Transl Med"},{"issue":"11","key":"10.1016\/j.ebiom.2020.103052_bib0060","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1152\/physiolgenomics.00075.2016","article-title":"Transcriptome assessment of the Pompe (Gaa-\/-) mouse spinal cord indicates widespread neuropathology","volume":"48","author":"Turner","year":"2016","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.ebiom.2020.103052_bib0061","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.resp.2015.11.013","article-title":"Altered activation of the diaphragm in late-onset Pompe disease","volume":"222","author":"Smith","year":"2016","journal-title":"Respir Physiol Neurobiol"},{"issue":"7","key":"10.1016\/j.ebiom.2020.103052_bib0062","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1096\/fj.201802488R","article-title":"Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy","volume":"33","author":"van Putten","year":"2019","journal-title":"FASEB J"},{"issue":"4-5","key":"10.1016\/j.ebiom.2020.103052_bib0063","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0960-8966(99)00117-0","article-title":"Modulation of disease severity in mice with targeted disruption of the acid alpha-glucosidase gene","volume":"10","author":"Raben","year":"2000","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ebiom.2020.103052_bib0064","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13395-015-0046-6","article-title":"Developmental myosins: expression patterns and functional significance","volume":"5","author":"Schiaffino","year":"2015","journal-title":"Skelet Muscle"},{"issue":"3","key":"10.1016\/j.ebiom.2020.103052_bib0065","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/jnen\/60.3.302","article-title":"Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment?","volume":"60","author":"Sandri","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.103052_bib0066","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40478-018-0609-y","article-title":"Satellite cells fail to contribute to muscle repair but are functional in Pompe disease (glycogenosis type II)","volume":"6","author":"Lagalice","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2020.103052_bib0067","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1038\/s41467-018-07253-3","article-title":"Age-related declines in alpha-Klotho drive progenitor cell mitochondrial dysfunction and impaired muscle regeneration","volume":"9","author":"Sahu","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2020.103052_bib0068","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/hmg\/ddv460","article-title":"Effect of genetic background on the dystrophic phenotype in mdx mice","volume":"25","author":"Coley","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.ebiom.2020.103052_bib0069","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2012.05.004","article-title":"Transcriptional response to GAA deficiency (Pompe disease) in infantile-onset patients","volume":"106","author":"Palermo","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ebiom.2020.103052_bib0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1750-1172-8-90","article-title":"Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy","volume":"8","author":"Prater","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2020.103052_bib0071","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ajpath.2011.02.024","article-title":"Inhibiting TGF-beta activity improves respiratory function in mdx mice","volume":"178","author":"Nelson","year":"2011","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.103052_bib0072","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13395-020-00224-7","article-title":"Acute conversion of patient-derived Duchenne muscular dystrophy iPSC into myotubes reveals constitutive and inducible over-activation of TGFbeta-dependent pro-fibrotic signaling","volume":"10","author":"Caputo","year":"2020","journal-title":"Skelet Muscle"},{"issue":"1-2","key":"10.1016\/j.ebiom.2020.103052_bib0073","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ebiom.2020.103052_bib0074","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.omtm.2020.05.026","article-title":"Enzyme replacement therapy can reverse pathogenic cascade in Pompe disease","volume":"18","author":"Meena","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"7","key":"10.1016\/j.ebiom.2020.103052_bib0075","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/hmg\/ddu727","article-title":"Biochemical, histological and functional correction of mucopolysaccharidosis type IIIB by intra-cerebrospinal fluid gene therapy","volume":"24","author":"Ribera","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.ebiom.2020.103052_bib0076","doi-asserted-by":"crossref","first-page":"e86696","DOI":"10.1172\/jci.insight.86696","article-title":"CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome)","volume":"1","author":"Motas","year":"2016","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.ebiom.2020.103052_bib0077","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neuroscience.2006.07.048","article-title":"Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival","volume":"143","author":"Wootz","year":"2006","journal-title":"Neuroscience"},{"issue":"18","key":"10.1016\/j.ebiom.2020.103052_bib0078","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1093\/hmg\/ddq273","article-title":"Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses","volume":"19","author":"Vitner","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.ebiom.2020.103052_bib0079","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2522\/ptj.20150122","article-title":"Diaphragm pacing as a rehabilitative tool for patients with Pompe disease who are ventilator-dependent: case series","volume":"96","author":"Smith","year":"2016","journal-title":"Phys Ther"},{"issue":"259","key":"10.1016\/j.ebiom.2020.103052_bib0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010018","article-title":"Targeting latent TGFbeta release in muscular dystrophy","volume":"6","author":"Ceco","year":"2014","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.ebiom.2020.103052_bib0081","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006019","article-title":"Overexpression of latent TGFbeta binding protein 4 in muscle ameliorates muscular dystrophy through Myostatin and TGFbeta","volume":"12","author":"Lamar","year":"2016","journal-title":"PLoS Genet"},{"issue":"8","key":"10.1016\/j.ebiom.2020.103052_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2018.10.077","article-title":"AMPK activation regulates LTBP4-dependent TGF-beta1 secretion by pro-inflammatory macrophages and controls fibrosis in Duchenne muscular dystrophy","volume":"25","author":"Juban","year":"2018","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.ebiom.2020.103052_bib0083","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135703","article-title":"TGF-beta-driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model","volume":"5","author":"Mazala","year":"2020","journal-title":"JCI Insight"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642030428X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642030428X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:02:21Z","timestamp":1762455741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642030428X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":83,"alternative-id":["S235239642030428X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.103052","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.103052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103052"}}